NDC 76436-403-01 - SOFSKIN TRIPLE ANTIBIOTIC PLUS PAIN RELIEF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76436-403
- Requested NDC
- 76436-403-01
- Package NDCs from labels
- 76436-403-01, 76436-403-11
- Manufacturer
- Viny Health and Beauty Products Inc
- Effective date
- 2024-07-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SOFSKIN TRIPLE ANTIBIOTIC PLUS PAIN RELIEF - Viny Health and Beauty Products Inc | Viny Health and Beauty Products Inc | 2024-07-15 | HUMAN OTC DRUG LABEL |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76436-403 | SOFSKIN TRIPLE ANTIBIOTIC PLUS PAIN RELIEF (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, PRAMOXINE HCL) OINTMENT [VINY HEALTH AND BEAUTY PRODUCTS INC] | 2 | Unmatched | 20240716_1d4dac91-a044-77e7-e063-6294a90ab497.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Polymyxin B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 72dd6de6-31d6-4a8f-881b-91af91ed9314 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Neomycin Sulfate | NEOMYCIN SULFATE | Teva Pharmaceuticals USA, Inc. | 777dbfab-f83e-4738-ae1e-78619a9f82a7 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | 057Y626693 |
| Neomycin Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Proficient Rx LP | 548089f3-29d8-4ba8-af21-9e04356ac29c | 2022-10-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | f5ef71ae-fca9-4a57-ae88-f2b2d195a179 | 2022-08-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| hydrocortisone acetate pramoxine HCl | HYDROCORTISONE ACETATE, PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 982f0862-2be8-4a65-8b61-8f3a95ab5951 | 2022-05-31 | Adverse reactions | 88AYB867L5 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 87a4c494-56f9-48f6-8592-d610c507a4fc | 2022-05-31 | Adverse reactions | 88AYB867L5 |
| hydrocortisone acetate pramoxine hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 9eea5875-d153-4bba-aee2-b1d1cd8b5e57 | 2022-05-31 | Adverse reactions | 88AYB867L5 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 98042cef-2839-49d6-a7bd-a1d29c74430b | 2022-05-02 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 601cab21-c211-4c34-be7b-f4fdd97a921a | 2022-05-02 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Polymyxin B | POLYMYXIN B SULFATE | Hikma Pharmaceuticals USA Inc. | 18daf0d1-b6f5-46f4-ab2f-01a594f3959c | 2022-04-28 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM | Proficient Rx LP | 1252b997-3a81-4f3c-90e4-92f29ba15713 | 2022-04-01 | Warnings, Adverse reactions | 19371312D4 |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | Proficient Rx LP | d1f55327-156f-44cd-b0fc-b1a938e8aa73 | 2022-04-01 | Warnings, Adverse reactions | 19371312D4 |
| Cuadriderma | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, AND PRAMOXINE HYDROCHLORIDE | ProMex LLC | 4fa99b96-ab4b-4523-82bc-343dbaf39fb6 | 2022-01-25 | Warnings | 89Y4M234ES 057Y626693 88AYB867L5 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Sandoz Inc | 96a7b0a5-030a-42dc-80cd-35c4e9aa1b6d | 2021-08-31 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Sandoz Inc. | 99d9030f-9118-412c-a377-d1df1c8fa723 | 2021-08-31 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| POLYMYXIN B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 704a41f5-b109-4c16-8d3e-1495c9917952 | 2021-05-31 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| POLYMYXIN B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | fbc12c18-567b-41bc-89d0-efd29616615c | 2021-02-28 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN, POLYMYXIN B SULFATES, DEXAMETHASONE | Proficient Rx LP | bd9f3220-6d42-4863-aa2a-b17b138d095d | 2021-01-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Trimethoprim sulfate and Polymyxin B sulfate | TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE | Proficient Rx LP | 2c5579eb-ad81-415e-8dcb-9f1c94c897ae | 2021-01-01 | Warnings, Adverse reactions | 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, HYDROCORTISONE | Proficient Rx LP | d55f1783-9c49-4f90-9ff8-6f132e7b325e | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 057Y626693 19371312D4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.